John brings more than 25 years of executive experience in biotech, pharmaceuticals, and healthcare consulting to his role as Chief Executive Officer at Invida. He has focused the company’s business development and marketing efforts, while using his international experience to bring companies and products from around the world into the Asia Pacific arena.

John has held senior management positions in Europe, the United States, and Latin America. Prior to joining Invida, he was President of Paramount Corporate Development, a biotech venture firm in New York. Earlier he was a Principal at Ernst & Young, where he built the Life Sciences Advisory Practice around business analytics and marketing effectiveness. Prior to his role at Ernst & Young, he was Managing Director of Genzyme’s operations in Germany and Switzerland, responsible for Genzyme’s diversified business portfolio in those countries. John started his career with Aventis, where he spent 18 years in global commercial leadership positions including regional responsibilities in Latin America, Head of Global Diabetes, and VP of New Products.

John graduated from the Imperial College of Science and Technology in London with a BSc (Hons) in Biochemistry.